Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Evaxion A/S logo — evaxion.ai

Evaxion A/S

evaxion.ai

Founded 2008 Denmark Denmark 51 employees Post Ipo Equity Total: $92.00M Biotechnology

General Information

Company Name Evaxion A/S
Founded Year 2008
Location Denmark Denmark +1
Founders / Decision Makers
Team member
Employees 51
Industries Biotechnology
Funding Stage Post Ipo Equity
Social

Get notified when Evaxion A/S moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Evaxion A/S

Evaxion A/S, established in 2008 and headquartered in Denmark, is a transformative player in the Biotechnology sector. The company leverages its groundbreaking AI-Immunology™ platform to decode the human immune system, tailoring innovative immunotherapies for cancer, bacterial, and viral diseases.

Utilizing proprietary AI prediction models, Evaxion A/S has advanced a clinical-stage oncology pipeline with personalized vaccines and a preclinical infectious disease pipeline addressing high unmet medical needs. This approach positions Evaxion A/S as a compelling investment opportunity in the rapidly evolving TechBio landscape.

Most recently, the company secured a $15.00M Post-IPO Equity investment on 01 February 2024, backed by distinguished investors including Merck Global Health Innovation Fund and City of Rahway. This capital infusion underscores substantial confidence in Evaxion A/S's innovative potential and commitment to transforming patients' lives.

Taxonomy: AI-Immunology, Immunotherapy, Cancer Immunotherapies, Personalized Vaccines, Infectious Disease Vaccines, Bioinformatics, Immunoinformatics, Antigen Discovery, Neo Epitope Discovery, Immuno-Oncology, Clinical-Stage Oncology, Bacterial Infections, Viral Infections, Proprietary AI Prediction Models

Services & Products

Vaccine target discovery
Drug design and development
Clinical trials and development
AI platform for immunotherapy

Target Customers

Pharmaceutical companies Biotech industries Healthcare providers Research institutions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 2 •••• •••• 01 Feb 2024
Post-IPO Debt •••••• 1
Investor
01 Aug 2023
Grant •••••• 1 •••• •••• 06 Sep 2022
Post-IPO Equity •••••• 1
Investor
07 Jun 2022
Venture Round •••••• - 20 Dec 2019

Evaxion A/S Alternatives & Competitors

Evaxion A/S vs
Advaccine
Advaccine China

Advancing Vaccines，Improving Immunotherapeutics

Private Equity
5 employees
Biopharma, Biotechnology
Compare Evaxion A/S vs Advaccine
Evaxion A/S vs
Pacific Genetech
Pacific Genetech United States

NextGen Vaccine Technologies

Series Unknown
9 employees
Agriculture, Biotechnology
Compare Evaxion A/S vs Pacific Genetech
Evaxion A/S vs
stoked bio
stoked bio Canada

code.compound.cure.

8 employees
Also compare with: Evaxion A/S vs STORM Therapeutics Limited STORM Therapeutics Limited

FAQ About Evaxion A/S

evaxion.ai
Evaxion A/S was founded in 2008.
Evaxion A/S is headquartered in Denmark.
Evaxion A/S operates in the following industries: Biotechnology.
Evaxion A/S has approximately 51 employees.
Evaxion A/S has completed 5 funding rounds, raising a total of $92.00M. The latest funding stage is Post Ipo Equity.
Evaxion A/S offers: Vaccine target discovery, Drug design and development, Clinical trials and development, AI platform for immunotherapy.
Top alternatives and competitors to Evaxion A/S include Advaccine, Pacific Genetech, stoked bio, STORM Therapeutics Limited, IrsiCaixa. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Evaxion A/S and Advaccine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Evaxion A/S and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes